{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-074032","form_type":"8-K","ticker":"CRBP","cik":"0001595097","company_name":"Corbus Pharmaceuticals Holdings, Inc.","filed_at":"2024-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.140252+00:00","generated_at":"2026-06-01T04:06:33.322579+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Corbus board member Dr. Yong Ben adopts 10b5-1 plan for up to 10,607 shares","bullets":["Dr. Yong Ben, a board member, adopted a Rule 10b5-1 trading plan on June 14, 2024.","Plan authorizes sale of up to 10,607 shares of CRBP common stock.","Sales may begin September 12, 2024; plan terminates September 11, 2025.","Plan is intended to satisfy affirmative defense under Rule 10b5-1(c)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-074032","json":"https://secwatch.observer/filing/0000950170-24-074032.json","markdown":"https://secwatch.observer/filing/0000950170-24-074032.md","text":"https://secwatch.observer/filing/0000950170-24-074032.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024074032/0000950170-24-074032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024074032/crbp-20240614.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:06:33.322579+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}